Treace Medical Concepts Reports Second Quarter 2022 Financial Results

Go back to Treace Medical Concepts Reports Second Quarter 2022 Financial Results

Treace Medical Concepts, Inc. (TMCI) Misses Q2 EPS by 2c

August 9, 2022 4:26 PM EDT

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $28.63 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

... More